Skip to main content
. 2015 Dec;110(8):981–988. doi: 10.1590/0074-02760150163

TABLE II. Selectivity indexes (SI), the ratio between in vitro cytotoxicity [minimum lethal dose for 50% of the cells (MLD50)] and activity [inhibitory concentration for 50% (IC50), mM] against Plasmodium falciparum (Pf) of tamoxifen-like compounds and metallic derivatives.

Compounds/ Structural MLD50 IC50 SI
series class HepG2a Pf (MLD50/IC50)
1/A Tamoxifen-like > 3516 83 ± 5 42
2/A < 10 2.2 ± 0.05 Toxic
3/B Ferrocifene 479 ± 89 16.6 ± 2.3 29
4/B < 7.7 0.7 ± 0.1 Toxic
5/B < 61 23.6 ± 9.8 Toxic
6/B < 61 23.6 ± 5.9 Toxic
7/C [3]ferrocenophane > 2562 62.8 ± 10.7 41
8/C < 63 5.9 ± 1.6 18
9/D Di-ferrocenyl derivative < 60 27.1 ± 23.2 Toxic
10/D < 60 7.8 ± 1.6 Toxic
11/E Ruthenocene 2248 ± 53 16.5 ± 0.5 136
12/E 251 ± 34 4.7 ± 1.3 53
13/E 266 ± 3 5.9 ± 2.3 45
CQ Quinoline 502 ± 52 0.1 ± 0.02 5,020

a: except for compounds 12 and 13, which were tested for cytotoxicity against normal monkey kidney cells using the neutral red method; CQ: chloroquine.